Details for New Drug Application (NDA): 020918
✉ Email this page to a colleague
NDA 020918 describes GLUCAGEN, which is a drug marketed by Novo Nordisk and is included in one NDA. It is available from two suppliers. Additional details are available on the GLUCAGEN profile page.
The generic ingredient in GLUCAGEN is glucagon hydrochloride. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the glucagon hydrochloride profile page.
The generic ingredient in GLUCAGEN is glucagon hydrochloride. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the glucagon hydrochloride profile page.
Summary for 020918
| Tradename: | GLUCAGEN |
| Applicant: | Novo Nordisk |
| Ingredient: | glucagon hydrochloride |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 020918
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| GLUCAGEN | glucagon hydrochloride | INJECTABLE;INJECTION | 020918 | NDA | Novo Nordisk | 0169-7065 | 0169-7065-15 | 1 KIT in 1 KIT (0169-7065-15) * 1 mL in 1 VIAL, GLASS * 1 mL in 1 SYRINGE, GLASS |
| GLUCAGEN | glucagon hydrochloride | INJECTABLE;INJECTION | 020918 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0053 | 0597-0053-45 | 10 VIAL in 1 CARTON (0597-0053-45) / 1 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1MG BASE/VIAL | ||||
| Approval Date: | Jun 22, 1998 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
